Saltagen Ventures
VC Fund
Central, Hong Kong
Saltagen Ventures is an early-stage venture capital firm that invests in science and technology-based startups.Its investment strategy focuses on the verticals of edtech, biomedical technology, AI and machine learning, and media technology. They search for startups that have strong defensibility and patentable technology and empowers them to growtheir business and develop efficiencies.The firm was founded in 2017 in Central, Hong Kong by Joseph Fung.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 24%
Last updated:
For AI agents: llms.txt
Industries Saltagen Ventures invests in
Stages Saltagen Ventures invests in
Countries Saltagen Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 6 (35%)
- Artificial Intelligence 5 (29%)
- Software 3 (18%)
- Biotechnology 3 (18%)
- Medical Device 3 (18%)
Stage
- Seed 9 (53%)
- Pre-Seed 2 (12%)
- Series A 2 (12%)
- Series B 1 (6%)
- Venture - Series Unknown 1 (6%)
Country
- Canada 6 (35%)
- Hong Kong 3 (18%)
- United States 3 (18%)
- Denmark 1 (6%)
- Australia 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Simon Lai
Chief Operating Officer
|
Chief Operating Officer | Total investments: 0 | Find email | |
Yina Chan
Principal
|
Principal | Total investments: 0 | Find email | |
Jason Chiu
Investment Committee Member
|
Investment Committee Member | Total investments: 1 | Find email | |
Joseph Fung
Managing Partner
|
Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Spot BioSystems is a bioengineering firm that specializes in personalized cancer treatments. The company's headquarters are in Palo Alto, California. | $40M / Venture - Series Unknown / Jun 17, 2026 | ||
| PulseMedica, an Edmonton-based medical device startup, is developing an ophthalmic medical device platform for non-invasive, automated image-guided laser treatment enabled by 3D computer vision, real-time tracking, and femtosecond laser technology. PulseMedica is laser-focused on improving the quality of life for millions of people by buildingrevolutionary technology to image and treat vitreoretinal disease. PulseMedica’s short-term vision is to become the global expert in non-invasive, safe, effective screening and treatment of eye floaters, with the ultimate vision of becoming the global standard for screening and treating vitreoretinal disease. | $8.7M / Seed / May 29, 2024 | ||
| Fano Labs provides automatic language detection and multilingual speech recognition, with capabilities for mixed-language transcription. The company’s proprietary automatic speech recognition models are designed for enterprise environments and focus on accuracy in complex, real-world conversations. Fano Labs enables organizations to analyze callrecordings, live chats, and emails to extract insights related to sales performance, compliance monitoring, operational workflows, and customer sentiment. | Series B / May 02, 2024 | ||
| Beatdapp offers a tracking system that authenticates, verifies, and validates media streamed in real-time.The service reduces the tracking discrepancies between Digital Service Providers (DSPs) and rights holders, increasing royalty revenue for rights holders while limiting legal exposure to royalty lawsuits for DSPs. Think of it like a PWC formusic play count. | $17M / Series A / Jan 19, 2024 | ||
| Child Health Imprints is engaged in the development and application of cutting edge informational and computational technologies including IoT, artificial intelligence and predictive analytics to the practice of medicine in neonatal intensive care units across the world with the objective of making early diagnosis of critical diseases and improvingoverall quality of healthcare which is being provided to neonates. | $2.5M / Seed / Jan 09, 2023 | ||
| Sympatic helps owners and users of sensitive data cooperate to extract value without ever risking their data or giving away their intellectual property. We do this by creating temporary, secure compute bastions in their cloud where algorithms meet data. We let them do this safely and repeatedly, even if they have no idea how to do complex cloudDevOps. | Pre-Seed / Aug 04, 2022 | ||
| Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | $5M / Seed / Jul 21, 2022 | ||
| CaroMeats grows healthy, delicious meat directly from animal cells. No environmental damage is caused. No animals are harmed. | $2M / Seed / May 19, 2022 | ||
| Modl.ai delivers game technology that accelerates game development and enhances player engagement around the world. | $1.7M / Seed / Feb 03, 2020 | ||
| Juno Diagnostics is a health technology company democratizing access to high-value genetic information. The company is developing simple, cost-effective devices that enable point-of-need genetic testing. It was founded in 2017 and is based in San Diego, California. | Seed / Jan 01, 2019 | ||
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Saltagen Ventures invest in?
Saltagen Ventures invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Pre-Seed stage. Most of the 17 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Saltagen Ventures?
Public channels for Saltagen Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Saltagen Ventures?
The team at Saltagen Ventures includes Simon Lai (Chief Operating Officer), Yina Chan (Principal) and Jason Chiu (Investment Committee Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
